正子斷層掃描（PET）市場規模、佔有率和成長分析（按產品、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

預計到 2024 年，正子斷層掃描 (PET) 市場規模將達到 26.9 億美元，到 2025 年將達到 28.6 億美元，到 2033 年將達到 47.8 億美元，在預測期（2026-2033 年）內，複合成長率為 6.61%。

癌症和阿茲海默症嚴重疾病的日益普及顯著推動了正子斷層掃描（PET）的需求成長。這些先進的成像技術能夠提供人體生理和代謝活動的重要訊息，使其成為精準診斷和持續患者照護的關鍵工具。慢性病的增加正推動著治療方案向標靶治療和個人化醫療轉變，而PET掃描在提供關鍵資訊以根據個別患者需求客製化治療方案方面發揮著重要作用。此外，分子成像技術的進步以及人工智慧和機器學習的融合正在增強PET掃描的功能，提高成像的準確性和效率。因此，PET掃描在檢查和臨床診斷領域的應用不斷擴展，從而推動了整體市場的成長。

正子斷層掃描（PET）市場成長要素

癌症、阿茲海默症和心血管疾病等慢性病發病率的不斷上升，顯著推動了正子斷層掃描（PET）市場的成長。這些複雜的疾病通常需要先進的成像技術進行精準診斷和後續觀察。 PET檢查在這一領域發揮關鍵作用，它能夠提供重要的代謝和生理活動訊息，這些資訊對於制定有效的治療策略和疾病管理至關重要。隨著慢性病患者數量的持續成長，對PET掃描的需求也不斷增加，這凸顯了先進診斷技術在應對這些疾病管理挑戰方面的必要性。

正子斷層掃描（PET）市場限制

正子斷層掃描（PET）市場面臨的主要挑戰之一是PET掃描儀的高昂成本。購買、營運和維護這些先進影像設備的費用構成了一大障礙，尤其對於預算有限的小規模醫療機構和診斷實驗室而言更是如此。這些經濟限制可能會阻礙資源匱乏地區獲得PET掃描技術，並使其無法惠及真正需要的病患。因此，PET掃描儀的高昂價格有可能抑制市場成長，並限制這項創新成像技術在各個應用領域的拓展。

正子斷層掃描（PET）市場趨勢

由於人工智慧 (AI) 和機器學習技術的融合，正子斷層掃描 (PET) 市場正經歷著一場變革。這些技術的進步最佳化了影像擷取、重建和分析，提高了診斷的準確性和效率，增強了對細微異常的檢測，並改善了腫瘤的特性。此外，機器學習工具能夠預測患者預後並客製化治療方案，進一步實現個人化患者照護。隨著人工智慧和機器學習技術的不斷發展，它們與 PET 系統的整合將徹底革新成像能力，進一步提升這項技術在臨床和科學研究領域的價值。

目錄

介紹

• 調查目標
• 定義
• 市場覆蓋範圍

調查方法

• 資訊收集
• 二手和一手資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

前景
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 抑制因素
  • 任務
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 價值鏈分析
• 供應鏈分析
• 專利分析
• 貿易分析
• 技術分析
• 監管環境
• 用例分析

正子斷層掃描（PET）市場依產品分類

• 獨立式PET系統
• PET/CT系統
  • 低切掃描儀
  • 中切掃描儀
  • 高切掃描器
• PET/MRI系統

按應用分類的正子斷層掃描（PET）市場

• 腫瘤學應用
• 神經學應用
• 心血管應用
• 其他

按最終用戶分類的正子斷層掃描（PET）市場

• 醫院及手術中心
• 診斷和影像診所
• 門診治療中心
• 其他

正子斷層掃描（PET）市場：按地區分類的市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • GCC
  • 南非
  • 其他中東和非洲地區

競爭格局

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市佔率（2025 年）

主要企業簡介

• General Electric
• Koninklijke Philips NV
• Siemens AG
• Shanghai United Imaging Healthcare Co., Ltd
• Canon Inc.
• Shimadzu Corporation
• Mediso Ltd.
• MinFound Medical Systems Co., Ltd
• Neusoft Corporation
• Bruker
• CMR Naviscan
• Kindsway BioTech
• Hermes Medical Solutions
• Sofie Biosciences
• Prescient Medical Imaging
• Reflexion
• Cubresa Inc.
• Synchropet, Inc.
• Novartis
• Revvity Inc.

Positron Emission Tomography Market size was valued at USD 2.69 Billion in 2024 and is poised to grow from USD 2.86 Billion in 2025 to USD 4.78 Billion by 2033, growing at a CAGR of 6.61% during the forecast period (2026-2033).

The rising prevalence of critical diseases, including cancer and Alzheimer's, is significantly boosting the demand for Positron Emission Tomography (PET) scans. These advanced imaging technologies are essential for accurate diagnosis and ongoing patient care, as they provide crucial insights into the body's physiological and metabolic activities. The increasing burden of chronic illnesses is fostering a shift towards targeted therapeutics and personalized medicine, with PET scans playing a key role by delivering vital information that tailors treatments to individual patient needs. Furthermore, advancements in molecular imaging and the integration of AI and machine learning are enhancing PET scan capabilities, leading to improved imaging accuracy and efficiency. Consequently, the adoption of PET scans is expanding across research and clinical diagnostics, propelling growth in the overall market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Positron Emission Tomography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Positron Emission Tomography Market Segments Analysis

Global Positron Emission Tomography Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Standalone PET Systems, PET/CT Systems (Low-Slice Scanners, Medium-Slice Scanners, High-Slice Scanners), PET/MRI Systems. Based on Application, the market is segmented into Oncology Applications, Neurological Applications, Cardiovascular Applications, Other Applications. Based on End User, the market is segmented into Hospitals & Surgical Centers, Diagnostic & Imaging Clinics, Ambulatory Care Centers, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Positron Emission Tomography Market

The rising incidence of chronic illnesses, including conditions like cancer, Alzheimer's, and cardiovascular diseases, significantly propels the growth of the Positron Emission Tomography (PET) market. These complex disorders often necessitate sophisticated imaging techniques for accurate diagnosis and ongoing evaluation. PET scans play a crucial role in this landscape by providing vital insights into metabolic and physiological activities, which are essential for effective treatment strategies and disease management. As the number of patients with chronic health issues continues to grow, the demand for PET scans intensifies, highlighting the need for advanced diagnostic technologies to navigate the challenges in managing these medical conditions.

Restraints in the Positron Emission Tomography Market

One of the significant challenges facing the Positron Emission Tomography market is the high expense associated with PET scanners. The costs incurred for purchasing, operating, and maintaining these advanced imaging devices pose considerable hurdles, particularly for smaller medical facilities and diagnostic laboratories with limited budgets. These financial constraints can restrict access to PET scan technology in resource-limited environments, potentially hindering its availability to patients who would benefit from it. As a result, the steep prices of PET scanners may impede market growth and limit the expansion of various applications of this innovative imaging technology.

Market Trends of the Positron Emission Tomography Market

The Positron Emission Tomography (PET) market is witnessing a transformative shift due to the integration of artificial intelligence (AI) and machine learning technologies. This advancement enhances diagnostic accuracy and efficiency by optimizing image capture, reconstruction, and analysis, leading to improved detection of minor anomalies and precise tumor characterization. Additionally, machine learning tools enable the prediction of patient outcomes and the customization of treatment strategies, further personalizing patient care. As AI and machine learning continue to evolve, their integration into PET systems is set to revolutionize imaging capabilities, making the technology increasingly valuable in clinical and research environments alike.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Supply Chain Analysis
• Patent Analysis
• Trade Analysis
• Technology Analysis
• Regulatory Landscape
• Case Study Analysis

Positron Emission Tomography Market, By Product

• Market Overview
• Standalone PET Systems
• PET/CT Systems
  • Low-Slice Scanners
  • Medium-Slice Scanners
  • High-Slice Scanners
• PET/MRI Systems

Positron Emission Tomography Market, By Application

• Market Overview
• Oncology Applications
• Neurological Applications
• Cardiovascular Applications
• Other Applications

Positron Emission Tomography Market, By End User

• Market Overview
• Hospitals And Surgical Centers
• Diagnostic And Imaging Clinics
• Ambulatory Care Centers
• Other End Users

Positron Emission Tomography Market Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• General Electric
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai United Imaging Healthcare Co., Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MinFound Medical Systems Co., Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neusoft Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMR Naviscan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindsway Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hermes Medical Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sofie Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prescient Medical Imaging
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reflexion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cubresa Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synchropet, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments